In addition, the expression of microchromosome maintenance protein 2 (MCM2) is highly correlated with the expression of YAP in HCC tissues and interference with MCM2 inhibits the Hippo pathway by blocking the entry of YAP into the nucleus, which increases the cells’ resistance to sorafenib (65). Here, MCM2 is linked to hepatocellular carcinoma.